Company Overview of Ramot at Tel Aviv University Ltd.
Ramot at Tel Aviv University Ltd. operates as a technology transfer company of Tel Aviv University (TAU) provides legal and commercial frameworks for inventions made by TAU faculty, students, and researchers. It licenses the university's intellectual property to third parties through agreements; facilitates collaborative research partnerships between business partners and tau researchers; establishes a company; and forms joint ventures that promote TAU technologies. The company supports agriculture, defense and security, electronics and electro-optics, environmental and cleantech, ICT and media, life sciences and biotechnology, material sciences, mechanical engineering, medical devices and d...
Tel-Aviv University Campus
The Senate Building
Tel Aviv, 6997801
Founded in 1973
Key Executives for Ramot at Tel Aviv University Ltd.
Vice President of Business Development - Life Sciences
Director of Business Development for Physical Sciences
Compensation as of Fiscal Year 2017.
Ramot at Tel Aviv University Ltd. Key Developments
Baxter International, Ramot at Tel Aviv University and Tel Aviv Sourasky Medical Center Partner to Bring New Surgical Innovations Worldwide
Jul 6 17
Baxter International Inc. and Tel Aviv University (TAU), through Ramot, its Business Engagement Center, announced new licensing agreements including global joint research efforts to evaluate multiple technologies currently under development at the university as well as at Tel Aviv Sourasky Medical Center (TASMC). Baxter will collaborate with TAU and TASMC to help bring the early-stage research to commercialization with the goal of bringing to market the latest innovations in surgical care. Under terms of the agreements, Baxter will exclusively license the TAU Technology Innovation Momentum Fund technology in one license agreement and TAU and TASMC technology in the second license agreement for use in multiple potential applications that might result from the joint research activity. Baxter, TAU and TASMC plan to explore potential applications of multiple projects that target large, unmet needs that, if successful, will expand Baxter’s portfolio of products into new areas of surgical care for the company. Surgical care represents a core strategic growth pillar for Baxter, and these projects have the potential to complement Baxter’s existing product offering and provide access to novel treatments.
Wipro Limited and Ramot at Tel Aviv University Collaborate for Joint Research in Emerging Technologies
Jul 5 17
Wipro Limited and Ramot at Tel Aviv University collaborate for joint research in emerging technologies the partnership envisages the creation of joint research capability at TAU supported by Wipro to pursue core as well as applied research in fast developing technologies in the artificial intelligence space.
Ramot to Collaborate with Merck KGaA on Developing Novel ADCs for Cancer
Feb 3 17
Tel Aviv University (Israel)'s business engagement company, Ramot, has announced that it has entered into a research collaboration agreement with Merck KGaA (Germany) with the aim of developing novel antibody drug conjugates (ADCs) for cancer therapy. The collaboration involves a novel type of chemical linkage developed by Tel Aviv University that enables the tagging of drugs or payloads that are considered untaggable, to ADCs, potentially significantly improving their efficacy and safety. The agreement provides Merck with the option to obtain a licence for Ramot's existing ADC linker technology, as well as for new discoveries made as a result of the collaboration.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|